<iframe src="//www.googletagmanager.com/ns.html?id=GTM-K3L4M3" height="0" width="0" style="display:none;visibility:hidden">

Features

Could a vaccine for cancer be within reach?

Have we reached a new stage in the war against cancer?

25 June 2022

9:00 AM

25 June 2022

9:00 AM

It’s probably now the longest running conflict since the Hundred Years’ War: Richard Nixon declared the ‘war on cancer’ 51 years ago. The enemy is still in the field, killing more people than ever as other causes of mortality shrink. But cancer is at last giving ground.

Fresh from its triumph in the race to make a vaccine for Covid-19, the German biotech company BioNTech has announced promising results using a similar vaccine against pancreatic cancer.

Already a subscriber? Log in

Easter flash sale:
10 issues for $1

Subscribe this Easter and get the next 10 issues of the magazine, plus website and app access, all for just $1.

  • Weekly delivery of the magazine
  • Unlimited access to spectator.com.au and app
  • Spectator Australia podcasts and newsletters
  • Full access to spectator.co.uk
Or

Unlock 3 articles a month

REGISTER

SPECTATOR.CO.UK/TV Matt Ridley and Professor Karol Sikora on the viability of mRNA vaccines for cancer.

You might disagree with half of it, but you’ll enjoy reading all of it. Try your first month for free, then just $2 a week for the remainder of your first year.


Comments

Easter flash sale: 10 issues for $1

Join the conversation with other Spectator Australia readers. Subscribe to leave a comment.

Already a subscriber? Log in

Close